Vertical_Talk Healthcare The Six Great Shifts
Treatment for Bladder Cancer
Biologics Manufacturing Center
ALS Therapeutics
e-Newsletter | Archives | Advertise


Actavis to acquire Allergan to Create Top 10 Global...

Advent International and Avista Capital Partners to...

Proteostasis and Astellas link...
Press Releases
Merck and NewLink Genetics enter into Licensing....

Dicerna Pharmaceuticals, Inc announces License Agreement...

Sunshine Biopharma signs agreement with Lonza to manufacture...


Nov 27 - Nov 29, 2014
4th Annual Symposium of Drug Delivery

Dec 1 - Dec 3, 2014
14th Annual World Drug Manufacturing Summit 2014

Dec 2 - Dec 4, 2014
P-MEC 2014
The Six Great Shifts
Transforming the pharma industry
Anyone involved with the life sciences sector can see how changes in technology, demographics and health economics are driving the industry...
Techno Trends  
British scientists discover major treatment for bladder cancer
A significant breakthrough in 30 years for treating the advanced bladder cancer.
A cancer immunotherapy medicine named MPDL3280A being developed by Roche, has been administered as part of first clinical trial keeping 68 people under observation where other treatments failed to cure.
AstraZeneca pharmaceutical invests $200 million for Frederick, Maryland biologics manufacturing center expansion
AstraZeneca’s Frederick biologics manufacturing center is an FDA licensed, large-scale cell culture production facility. The site currently produces a pediatric medication, as well as other investigational biologic products.
Research Insights  
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Here, we prove that a P-gp/BCRP-driven pharmacoresistance limits the bioavailability of ALS therapeutics using riluzole, the only FDA-approved drug for ALS and a substrate of P-gp and BCRP. ALS mice (SOD1-G93A) were treated with riluzole and elacridar...
Current Issue
Current Issue
Editorial Calender
Media Pack
e-Magazine| Subscribe | Unsubscribe Pharma Focus Asia – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555